Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous aspergillosis

M Isaac1

  • 1Department of Dermatology, Medical College of Pennsylvania/Hahnemann University, Philadelphia, USA.

Dermatologic Clinics
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Aspergillosis, a fungal infection from Aspergillus mold, rarely affects healthy individuals but can be severe in immunocompromised patients. Early detection and treatment are crucial for managing this opportunistic infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of amino acid sequence in a peptidic Cu<sup>+</sup>-responsive luminescent probe inspired by the copper chaperone CusF.

Organic & biomolecular chemistry·2018
Same author

Editorial: Collaborative Efforts to Prevent Alzheimer's Disease.

The journal of nutrition, health & aging·2017
Same author

EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.

The journal of prevention of Alzheimer's disease·2017
Same author

Mental Hospitals in India in the 21st century: transformation and relevance.

Epidemiology and psychiatric sciences·2016
Same author

Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up.

Eye (London, England)·2016
Same author

Using a commercial software package to support treatment planning peer review activities in small radiotherapy departments.

The British journal of radiology·2015
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Dermatology

Background:

  • Aspergillosis is caused by Aspergillus, a common mold found in decaying vegetation.
  • It typically affects immunocompromised individuals, leading to invasive and severe disease.
  • It is the second most common opportunistic fungal infection after candidiasis.

Purpose of the Study:

  • To review the historical, etiological, epidemiological, clinical, and pathological aspects of aspergillosis.
  • To focus on the cutaneous manifestations of Aspergillus infections in humans.
  • To emphasize the importance of early detection and treatment.

Main Methods:

  • Literature review of historical, etiological, epidemiological, clinical, and pathological data.
  • Focus on clinical manifestations, particularly cutaneous aspergillosis.

Related Experiment Videos

  • Synthesis of current treatment strategies.

    • Main Results:

    • Aspergillus species are ubiquitous molds, rarely pathogenic in immunocompetent hosts.
    • Immunosuppression significantly increases the risk of invasive aspergillosis.
    • Cutaneous aspergillosis represents a specific clinical manifestation requiring targeted management.

    Conclusions:

    • Aspergillosis poses a significant threat as an opportunistic infection, especially in immunocompromised populations.
    • Comprehensive understanding of the disease spectrum, including cutaneous forms, is vital.
    • Prompt diagnosis and effective treatment are essential to reduce aspergillosis-related morbidity and mortality.